CRISPRi-Mediated Silencing of Burkholderia O-Linked Glycosylation Systems Enables the Depletion of Glycosylation Yet Results in Modest Proteome Impacts
Journal of Proteome Research · 2023
DOI: 10.1021/acs.jproteome.2c00790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2023. Verfasst von Jessica M Lewis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Austral…. Hauptthemen laut MEDLINE: Proteome, Burkholderia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council.
Abstract (Originalsprache)
The process of O-linked protein glycosylation is highly conserved across the Burkholderia genus and mediated by the oligosaccharyltransferase PglL. While our understanding of Burkholderia glycoproteomes has increased in recent years, little is known about how Burkholderia species respond to modulations in glycosylation. Utilizing CRISPR interference (CRISPRi), we explored the impact of silencing of O-linked glycosylation across four species of Burkholderia; Burkholderia cenocepacia K56-2, Burkholderia diffusa MSMB375, Burkholderia multivorans ATCC17616, and Burkholderia thailandensis E264. Proteomic and glycoproteomic analyses revealed that while CRISPRi enabled inducible silencing of PglL, this did not abolish glycosylation, nor recapitulate phenotypes such as proteome changes or alterations in motility that are associated with glycosylation null strains, despite inhibition of glycosylation by nearly 90%. Importantly, this work also demonstrated that CRISPRi induction with high levels of rhamnose leads to extensive impacts on the Burkholderia proteomes, which without appropriate controls mask the impacts specifically driven by CRISPRi guides. Combined, this work revealed that while CRISPRi allows the modulation of O-linked glycosylation with reductions up to 90% at a phenotypic and proteome levels, Burkholderia appears to demonstrate a robust tolerance to fluctuations in glycosylation capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne 3000, Australia.
ORCID-Profile: Nichollas E Scott
Förderung
- National Health and Medical Research Council
- Australian Research Council
Zitieren
APA
Lewis, J. M., & Scott, N. E. (2023). CRISPRi-Mediated Silencing of Burkholderia O-Linked Glycosylation Systems Enables the Depletion of Glycosylation Yet Results in Modest Proteome Impacts. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.2c00790
Vancouver
Lewis JM, Scott NE. CRISPRi-Mediated Silencing of Burkholderia O-Linked Glycosylation Systems Enables the Depletion of Glycosylation Yet Results in Modest Proteome Impacts. Journal of Proteome Research. 2023. doi:10.1021/acs.jproteome.2c00790
BibTeX
@article{Lewis2023,
author = {Lewis, Jessica M and Scott, Nichollas E},
title = {CRISPRi-Mediated Silencing of Burkholderia O-Linked Glycosylation Systems Enables the Depletion of Glycosylation Yet Results in Modest Proteome Impacts},
journal = {Journal of Proteome Research},
year = {2023},
doi = {10.1021/acs.jproteome.2c00790}
}
EUVIMED